However, both P2Y2 and P2Y6 receptor subtypes have actually been demonstrated to mediate pro-inflammatory effects in bronchial asthma or chronic obstructive pulmonary disease [12, 18, 19]. This evidence concerns the gene P2RY6 and chronic obstructive pulmonary disease.